Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-23

Clinical Trial Update: Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating intensification with Interferon Alpha 2b in HIV-positive individuals on antiretroviral therapy; completed with results posted in 2019…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Interferon-alpha-2b (interferon alfa-2b)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: HIV Infection | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-04-23